Avicanna Inc. is an emerging biopharmaceutical company engaged in the research, development and commercialization of novel cannabinoid-based health, wellness, and medical products. Avicanna focuses on the development of plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics, and cannabis extracts and purified cannabinoids.
Headquartered in Toronto, Canada, Avicanna aims to become a leader in the global medical cannabis industry through its product discovery and development processes and its intellectual property portfolio, supply chain controls, strategic relationships, and regulatory and scientific expertise.
Avicanna is growing its network of strategic relationships with best-in-class institutions located around the world. These strategic partners assist Avicanna in achieving its business objectives ranging from high quality cultivation and manufacturing in Colombia to world class scientific research and development in Toronto to market leading distribution and sales worldwide.